|
Volumn 18, Issue 5, 2010, Pages 2029-2036
|
Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols
|
Author keywords
Anti HIV activity; Antivirals; CEM GFP cells; Phloroglucinol
|
Indexed keywords
1 3 ACETYL 5 (3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYL) 2 PHENYLETHYLMETHYL 2,4,6 TRIHYDROXYPHENYLETHANONE;
1 3 ACETYL 5 (3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYLCYCLOHEXYLMETHYL) 2,4,6 TRIHYDROXYPHENYLETHANONE;
1 3 ACETYL 5 (3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYLETHYLMETHYL) 2,4,6-TRIHYDROXYPHENYLETHANONE;
1 3 ACETYL 5 [(3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYL) 4 HYDROXYPHENYLMETHYL] 2,4,6 TRIHYDROXYPHENYLETHANONE;
1 3 ACETYL 5 [(3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYL) QUINOLIN 4 YLMETHYL] 2,4,6 TRIHYDROXYPHENYLETHANONE;
1 [3 ACETYL 5 ((3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYL) 4 N,N DIMETHYLAMINOPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] ETHANONE;
1 [3 ACETYL 5 (3,5 DIACETYL 2,4,6 TRIHYDROXYPHENYLFURAN 2 YLMETHYL) 2,4,6 TRIHYDROXYPHENYL] ETHANONE;
1 [3 FORMYL 5 ((5 FORMYL 3 ISOPENTANOYL 2,4,6 TRIHYDROXYPHENYL) 4 BENZYLOXYPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 FORMYL 5 (5 FORMYL 3 ISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLPYRIDIN 2 YLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 ((3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYL) 3,4 METHYLENEDIOXYPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 ((3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYL) 4 BENZYLOXYPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 ((3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYL) 4 HYDROXYPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 (3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLFURAN 2 YLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 (3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLPHENYLETHYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 (3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLPHENYLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 (3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLPYRIDIN 2 YLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
1 [3 ISOPENTANOYL 5 (3,5 DIISOPENTANOYL 2,4,6 TRIHYDROXYPHENYLQUINOLIN 4 YLMETHYL) 2,4,6 TRIHYDROXYPHENYL] 3 METHYLBUTAN 1 ONE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
METHYLENE BIS (3 FORMYL 5 ISOPENTANOYL 2,4,6 TRIHYDROXYBENZENE);
METHYLENE BIS (3,5 DI ISOBUTANOYL 2,4,6 TRIHYDROXYBENZENE);
METHYLENE BIS (3,5 DI ISOPENTANOYL 2,4,6 TRIHYDROXYBENZENE);
METHYLENE BIS (3,5 DIACETYL 2,4,6 TRIHYDROXY BENZENE);
NEVIRAPINE;
PHLOROGLUCINOL;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
ARTICLE;
CD4+ T LYMPHOCYTE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
IC 50;
STRUCTURE ACTIVITY RELATION;
ANTI-HIV AGENTS;
BIOMIMETIC MATERIALS;
DIMERIZATION;
HIV INFECTIONS;
HIV REVERSE TRANSCRIPTASE;
HUMANS;
PHLOROGLUCINOL;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 77549083227
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.01.023 Document Type: Article |
Times cited : (46)
|
References (34)
|